Latest News about TSHA

Recent news which mentions TSHA

< Previous 1 2 3 4 5 6 7 Next >

Stocks That Hit 52-Week Lows On Friday

April 29, 2022

Stocks That Hit 52-Week Lows On Tuesday

April 26, 2022

What 6 Analyst Ratings Have To Say About Taysha Gene Therapies

April 01, 2022

10 Biggest Price Target Changes For Friday

April 01, 2022

Taysha Gene Therapies, Inc. (TSHA) Q4 2021 Earnings Call Transcript

March 31, 2022

Taysha Gene Therapies Lays Off 35% Of staff, Narrows R&D Focus

March 31, 2022

Recap: Taysha Gene Therapies Q4 Earnings

March 31, 2022

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall

March 31, 2022

Earnings Scheduled For March 31, 2022

March 31, 2022

Taysha Gene Therapies's Earnings Outlook

March 30, 2022

The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict

March 30, 2022

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 2022

Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know

March 25, 2022

Stocks That Hit 52-Week Lows On Tuesday

March 15, 2022

Stocks That Hit 52-Week Lows On Monday

March 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2022

March 09, 2022

Stocks That Hit 52-Week Lows On Tuesday

March 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022

March 01, 2022

Stocks That Hit 52-Week Lows On Tuesday

February 22, 2022

Two Insider Moonshots Rising on Sudden Buying

February 10, 2022

Executives Buy Around $62M Of 3 Stocks

February 07, 2022

Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial

January 31, 2022

Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial

January 27, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

January 20, 2022

Stocks That Hit 52-Week Lows On Wednesday

January 19, 2022

Stocks That Hit 52-Week Lows On Thursday

January 06, 2022

Stocks Hitting New 52-Week Lows Today

January 03, 2022

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year

December 26, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021

December 16, 2021

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré

December 07, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.